Skip to main content

Artefacts and Normal Variants in Whole-Body PET and PET/CT Imaging

  • Chapter
Positron Emission Tomography

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 219.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 379.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Torizuka T, Tamaki N, Inokuma T et al. In vivo assessment of glucose metabolism in hepatocellular carcinoma with FDG-PET. J Nucl Med 1995;36(10):1811–1817.

    PubMed  CAS  Google Scholar 

  2. Minn H, Clavo AC, Wahl RL. Influence of hypoxia on tracer accumulation in squamous cell carcinoma: in vitro evaluation for PET imaging. Nucl Med Biol 1996;23:941–946.

    Article  PubMed  CAS  Google Scholar 

  3. Wahl RL, Henry CA, Ethier SP. Serum glucose: effects on tumour and normal tissue accumulation of 2-[F-18]-fluoro-2-deoxy-D-glucose in rodents with mammary carcinoma. Radiology 1992;183:643–647.

    PubMed  CAS  Google Scholar 

  4. Torizuka T, Clavo AC, Wahl RL. Effect of hyperglycaemia on in vitro tumour uptake of tritiated FDG, thymidine, L-methionine and L-leucine. J Nucl Med 1997;38:382–386.

    PubMed  CAS  Google Scholar 

  5. Yasuda S, Kajihara M, Fujii H, Takahashi W, Ide M, Shohtsu A. Factors influencing high FDG uptake in the intestine, skeletal muscle and myocardium. J Nucl Med 1999;40:140P.

    Google Scholar 

  6. Torizuka T, Fisher SJ, Wahl RL. Insulin induced hypoglycaemia decreases uptake of 2-[F-18]fluoro-2-deoxy-D-glucose into experimental mammary carcinoma. Radiology 1997;203:169–172.

    PubMed  CAS  Google Scholar 

  7. Yamada S, Kubota K, Kubota R et al. High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue. J Nucl Med 1995;36:1301–1306.

    PubMed  CAS  Google Scholar 

  8. Kubota R, Kubota K, Yamada S et al. Methionine uptake by tumor tissue: a microautoradiographic comparison with FDG. J Nucl Med 1995; 36:484–492.

    PubMed  CAS  Google Scholar 

  9. Sugawara Y, Braun DK, Kison PV, et al. Rapid detection of human infections with fluorine-18 fluorodeoxyglucose and positron emission tomography: preliminary results. Eur J Nucl Med 1998;25:1238–1243.

    Article  PubMed  CAS  Google Scholar 

  10. Reinhardt MJ, Kubota K, Yamada S, Iwata R, Yaegashi H. Assessment of cancer recurrence in residual tumors after fractionated radiotherapy: a comparison of fluorodeoxyglucose, L-methionine and thymidine. J Nucl Med 1997;38:280–287.

    PubMed  CAS  Google Scholar 

  11. Strauss LG. Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients. Eur J Nucl Med 1996;23:1409–1415.

    Article  PubMed  CAS  Google Scholar 

  12. Haberkorn U, Strauss LG, Dimitrakopoulou A et al. PET studies of fluorodeoxyglucose metabolism in patients with recurrent colorectal tumors receiving radiotherapy. J Nucl Med 1991;32:1485–1490.

    PubMed  CAS  Google Scholar 

  13. Kubota R, Kubota K, Yamada S et al. Methionine uptake by tumour tissue: a microautoradiographic comparison with 18FDG. J Nucl Med 1995;36:484–492.

    PubMed  CAS  Google Scholar 

  14. Nuutinen JM, Leskinen S, Elomaa I et al. Detection of residual tumours in postchemotherapy testicular cancer by FDG-PET. Eur J Cancer. 1997;33:1234–1241.

    Article  PubMed  CAS  Google Scholar 

  15. Jones DN, McCowage GB, Sostman HD et al. Monitoring of neoadjuvant therapy response of soft-tissue and musculoskeletal sarcoma using fluorine-18-FDG PET. J Nucl Med 1996;37:1438–1444.

    PubMed  CAS  Google Scholar 

  16. Shreve PD, Anzai Y, Wahl RL. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics 1999;19:61–77.

    PubMed  CAS  Google Scholar 

  17. Kato T, Tsukamoto E, Suginami Y et al. Visualization of normal organs in whole-body FDG-PET imaging. Jpn J Nucl Med 1999;36:971–977.

    CAS  Google Scholar 

  18. Yasuda S, Shohtsu A, Ide M et al. Chronic thyroiditis: diffuse uptake of FDG at PET. Radiology 1998;207:775–778.

    PubMed  CAS  Google Scholar 

  19. Miyauchi T. Wahl RL. Regional 2-[18F]fluoro-2-deoxy-D-glucose uptake varies in normal lung. Eur J Nucl Med 1996; 23:517–523.

    Article  PubMed  CAS  Google Scholar 

  20. Kubota K, Kubota R, Yamada S, Tada M, Takahashi T, Iwata R. Reevaluation of myocardial FDG uptake in hyperglycaemia. J Nucl Med 1996;37:1713–1717.

    PubMed  CAS  Google Scholar 

  21. Knuuti MJ, Maki M, Yki-Jarvinen et al. The effect of insulin and FFA on myocardial glucose uptake. J Mol Cell Cardiol 1995;27:1359–1367.

    Article  PubMed  CAS  Google Scholar 

  22. Choi Y, Brunken RC, Hawkins RA et al. Factors affecting myocardial 2-[F-18]fluoro-2-deoxy-D-glucose uptake in positron emission tomography studies of normal humans. Eur J Nucl Med 1993;20:308–318.

    Article  PubMed  CAS  Google Scholar 

  23. Bax JJ, Visser FC, Raymakers PG et al. Cardiac 18F-FDG-SPET studies in patients with non-insulin dependent diabetes mellitus during hyperinsulinaemic euglycaemic clamping. Nucl Med Commun 1997;18:200–206.

    PubMed  CAS  Google Scholar 

  24. Huitink JM, Visser FC, van Leeuwen GR et al. Influence of high and low plasma insulin levels on the uptake of fluorine-18 fluorodeoxyglucose in myocardium and femoral muscle assessed by planar imaging. Eur J Nucl Med 1995;22:1141–1148.

    Article  PubMed  CAS  Google Scholar 

  25. Locher JT, Frey LD, Seybold K, Jenzer H. Myocardial 18F-FDG-PET. Experiences with the euglycaemic hyperinsulinaemic clamp technique. Angiology 1995;46:313–320.

    Article  PubMed  CAS  Google Scholar 

  26. Ohtake T, Yokoyama I, Watanabe T et al. Myocardial glucose metabolism in noninsulin dependent diabetes mellitus patients evaluated by FDG-PET. J Nucl Med 1995;36:456–463.

    PubMed  CAS  Google Scholar 

  27. Bax JJ, Veening MA, Visser FC et al. Optimal metabolic conditions during fluorine-18 fluorodeoxyglucose imaging: a comparative study using different protocols. Eur J Nucl Med 1997;24:35–41.

    Article  PubMed  CAS  Google Scholar 

  28. Engel H, Steinert H, Buck A et al. Whole body PET: physiological and artifactual fluorodeoxyglucose accumulations. J Nucl Med 1996;37:441–446.

    PubMed  CAS  Google Scholar 

  29. Cook GJR, Fogelman I, Maisey M. Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron emission tomography scanning: potential for error in interpretation. Semin Nucl Med 1996;24:308–314.

    Article  Google Scholar 

  30. Cook GJR, Maisey MN, Fogelman I. Normal variants, artefacts and interpretative pitfalls in PET imaging with 18-fluoro-2-deoxyglucose and carbon-11 methionine. Eur J Nucl Med 1999;26:1363–1378.

    Article  PubMed  CAS  Google Scholar 

  31. Hany TF, Gharehpapagh E, Kamel EM et al. Brown adipose tissue: a factor to consider in symmetrical tracer uptake in the neck and upper chest region. Eur J Nucl Med 2002;29:1393–1398.

    Article  Google Scholar 

  32. Bischof Delalove A, Wahl RL. How high a level of FDG abdominal activity is considered normal? J Nucl Med 1995;36:106P.

    Google Scholar 

  33. Nakada K, Fisher SJ, Brown RS, Wahl RL. FDG uptake in the gastrointestinal tract: can it be reduced? J Nucl Med 1999;40:22P–23P.

    Google Scholar 

  34. Kosuda S, Fisher S, Kison PV, Wahl RL, Grossman HB. Uptake of 2-deoxy-2-[18F]fluoro-D-glucose in the normal testis: retrospective PET study and animal experiment. Ann Nucl Med 1997;11:195–199.

    Article  PubMed  CAS  Google Scholar 

  35. Picard Y, Thompson CJ. Motion correction of PET images using multiple acquisition frames. IEEE Trans Med Imaging 1997;16:137–144.

    Article  PubMed  CAS  Google Scholar 

  36. Nunez RF, Yeung HW, Macapinlac HA, Larson SM. Does post-radiation therapy changes in the lung affect the accuracy of FDG PET in the evaluation of tumour recurrence in lung cancer. J Nucl Med 1999;40:234P.

    Google Scholar 

  37. Diederichs CG, Staib L, Vogel J et al. Values and limitations of 18F-fluorodeoxyglucose-positron-emission tomography with preoperative evaluation of patients with pancreatic masses. Pancreas 2000;20:109–116.

    Article  PubMed  CAS  Google Scholar 

  38. Knopp MV, Bischoff HG. Evaluation of pulmonary lesions with positron emission tomography. Radiologe 1994;34:588–591.

    PubMed  CAS  Google Scholar 

  39. Lewis PJ, Salama A. Uptake of Fluorine-18-Fluorodeoxyglucose in sarcoidosis. J Nucl Med 1994;35:1–3.

    Google Scholar 

  40. O’Doherty MJ, Barrington SF, Campbell M, et al; PET scanning and the human immunodeficiency virus-positive patient. J Nucl Med 1997;38:1575–1583.

    PubMed  CAS  Google Scholar 

  41. Goerres GW, Kamel E, Seifert B et al. Accuracy of image coregistration of pulmonary lesions in patients with non-small cell lung cancer using an integrated PET/CT system. J Nucl Med 2002;43:1469–1475.

    PubMed  Google Scholar 

  42. Goerres GW, Kamel E, Heidelberg TN et al. PET-CT image coregistration in the thorax: influence of respiration. Eur J Nucl Med 2002;29:351–360.

    Article  CAS  Google Scholar 

  43. Goerres GW, Burger C, Schwitter MR et al. PET/CT of the abdomen: optimizing the patient breathing pattern. Eur Radiol 2003;13:734–739.

    Article  PubMed  Google Scholar 

  44. Osman MM, Cohade C, Nakamoto Y et al. Clinically significant inaccurate localization of lesions with PET/CT: frequency in 300 patients. J Nucl Med 2003;44:240–243.

    PubMed  Google Scholar 

  45. Dizendorf E, Hany TF, Buck A et al. Cause and magnitude of the error induced by oral CT contrast agent in CT-based attenuation correction of PET emission studies. J Nucl Med 2003;44:732–738.

    PubMed  Google Scholar 

  46. Goerres GW, Hany TF, Kamel E et al. Head and neck imaging with PET and PET/CT: artefacts from dental metallic implants. Eur J Nucl Med 2002;29:367–370.

    Article  CAS  Google Scholar 

  47. Kamel EM. Burger C. Buck A. von Schulthess GK. Goerres GW. Impact of metallic dental implants on CT-based attenuation correction in a combined PET/CT scanner. Eur Radiol 2003;13:724–728.

    PubMed  Google Scholar 

  48. Antoch G, Freudenberg LS, Egelhof T et al. Focal tracer uptake: a potential artifact in contrast-enhanced dual-modality PET/CT scans. J Nucl Med 2002;43:1339–1342.

    PubMed  Google Scholar 

  49. Cohade C, Wahl RL. Applications of PET/CT image fusion in clinical PET — Clinical use, interpretation methods, diagnostic improvements. Semin Nucl Med 2003;33:228–237.

    Article  PubMed  Google Scholar 

  50. Goerres GW, Ziegler SI, Burger C et al. Artifacts at PET and PET/CT caused by metallic hip prosthetic material. Radiology 2003;226:577–584.

    PubMed  Google Scholar 

  51. Kinahan PE, Hasegawa BH, Beyer T. X-ray based attenuation correction for PET/CT scanners. Semin Nucl Med 2003;33:166–179.

    Article  PubMed  Google Scholar 

  52. Cohade C, Osman M, Nakamoto Y et al. Initial experience with oral contrast in PET/CT: phantom and clinical studies. J Nucl Med 2003;44:412–416.

    PubMed  Google Scholar 

  53. Dizendorf EV, Treyer V, Von Schulthess Gk et al. Application of oral contrast media in coregistered positron emission tomography-CT. AJR 2002;179:477–481.

    PubMed  Google Scholar 

  54. Hany TF, Steinert HC, Goerres GW et al. PET diagnostic accuracy: improvement with in-line PET-CT system: initial results. Radiology 2002;225:575–581.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag London Limited

About this chapter

Cite this chapter

Cook, G.J.R. (2005). Artefacts and Normal Variants in Whole-Body PET and PET/CT Imaging. In: Bailey, D.L., Townsend, D.W., Valk, P.E., Maisey, M.N. (eds) Positron Emission Tomography. Springer, London. https://doi.org/10.1007/1-84628-007-9_14

Download citation

  • DOI: https://doi.org/10.1007/1-84628-007-9_14

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-85233-798-8

  • Online ISBN: 978-1-84628-007-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics